This website uses cookies to enhance the user experience.
G

GE HEALTHCARE HOLDING AS987 015 225

Process industry
Limited company
Vitaminveien 1A 0485 OSLO, Norge

GE HEALTHCARE HOLDING AS

Keywords

productionmedicinal substancesdrugsantibioticsbasic vitaminssalicylic acido-acetylsalicylic acidprocessing of blood

Organization

Chairman of the board
Years since formation
20 years
since Jul 2, 2004
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,160,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2023
-18,191,000
NOK
Total equity 2023
51,397,851,000
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
1,160,000
100 %

Shares owned by the GE HEALTHCARE HOLDING AS

NameShare classNumber of sharesShare
Ordinary shares
4,000
100 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-18,191,000
13,583,834,000
1,884,465,000
Total assets
69,461,257,000
68,662,868,000
66,497,030,000
Total liabilities
18,063,406,000
43,355,796,000
47,434,592,000
Total equity
51,397,851,000
25,307,073,000
19,062,438,000

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
0
0
0
Operating result
0
0
0
Financial income/costs
478,861,000
14,017,203,000
2,339,311,000
Profit before tax
478,861,000
14,017,203,000
2,339,311,000
Total tax & extraordinary income/cost
497,052,000
433,369,000
454,846,000
Annual Total Result
-18,191,000
13,583,834,000
1,884,465,000

Balance overview

Year202320222021
Total fixed assets
66,366,352,000
66,366,352,000
63,649,194,000
Total current assets
3,094,906,000
2,296,517,000
2,847,836,000
Total assets
69,461,257,000
68,662,868,000
66,497,030,000
Short term debt
563,406,000
477,051,000
4,555,847,000
Long term debt
17,500,000,000
42,878,745,000
42,878,745,000
Total liabilities
18,063,406,000
43,355,796,000
47,434,592,000
Contributed capital
30,944,560,000
4,835,590,000
4,835,590,000
Retained earnings
20,453,291,000
20,471,483,000
14,226,848,000
Total equity
51,397,851,000
25,307,073,000
19,062,438,000
Total equity and liabilities
69,461,257,000
68,662,868,000
66,497,030,000

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1
Main industrial group
Manufacture of basic pharmaceutical products
21.10
Industrial group
Manufacture of basic pharmaceutical products
21.100
Industrial group
Manufacture of basic pharmaceutical products